47 results on '"dal Bello, M."'
Search Results
2. Resistin is associated with overall survival in non-small cell lung cancer patients during nivolumab treatment
3. Experimental evidence of spatial signatures of approaching regime shifts in macroalgal canopies
4. Spatio-temporal variability in Mediterranean rocky shore microphytobenthos
5. The role of CEA, CYFRA21-1 and NSE in monitoring tumor response to Nivolumab in advanced non-small cell lung cancer (NSCLC) patients
6. Role of microRNAs in malignant mesothelioma
7. Sequential use of vinorelbine followed by gefitinib enhances the antitumor effect in NSCLC cell lines poorly responsive to reversible EGFR tyrosine kinase inhibitors
8. The immune metabolic prognostic index discloses the presence of radiological progression in patients with non-small cell lung cancer (NSCLC) treated with Nivolumab
9. Inversion of pheromone preference optimizes foraging inC. elegans
10. Vitamin D plasma level can affect nivolumab drug exposure in a cohort of patients with non-small-cell lung cancer
11. Antidesmoplakin antibodies in pemphigus vulgaris
12. Immune-related Adverse Events of Pembrolizumab in a Large Real-world Cohort of Patients With NSCLC With a PD-L1 Expression ≥ 50% and Their Relationship With Clinical Outcomes
13. Clinicopathologic correlates of first-line pembrolizumab effectiveness in patients with advanced NSCLC and a PD-L1 expression of ≥ 50
14. Taxonomic vs functional patterns across European marine benthic habitats: using research infrastructures (LIFEWATCH, ESFRI) in large-scale ecology
15. Essence of the patterns of cover and richness of intertidal hard bottom communities: a pan-European study
16. The role of physical variables in biodiversity patterns of intertidal macroalgae along European coasts
17. Consistent patterns of spatial variability between NE Atlantic and Mediterranean rocky shores
18. Geographic patterns of biodiversity in European coastal marine benthos
19. Serum proteomic test in advanced non-squamous non-small cell lung cancer treated in first line with standard chemotherapy
20. Effects of grazer diversity on marine microphytobenthic biofilm: a ‘tug of war’ between complementarity and competition
21. Skin toxicities difference between erlotinib (E) and gefitinib (G) in the treatment of advanced non-small-cell lung cancer (NSCLC)
22. Antidesmoplakin antibodies in pemphigus vulgaris
23. Serum proteomic test in advanced non-squamous non-small cell lung cancer treated in first line with standard chemotherapy.
24. CTL ANTIGEN 4 (CTLA-4) AND KI67 AS PROGNOSTIC FACTORS IN RESECTED STAGE I-III NON-SMALL CELL LUNG CANCER (NSCLC) PATIENTS
25. DRUGS FREE OF CHARGE IN LUNG CANCER TRIALS: AN ANALYSIS OF PHARMACEUTICAL COST SAVINGS
26. LUNG CANCER (LC) RISKS IN WOMEN WITH PREVIOUS BREAST CANCER (BC): ANALYSIS OF CLINICOPATHOLOGICAL CHARACTERISTICS AND BIOMARKERS EXPRESSION
27. Correlation between cell-free DNA and survival in patients receiving Nivolumab for advanced non-small cell lung cancer
28. Disease stabilization (SD) as a surrogate end-point in advanced non-small-cell lung cancer (NSCLC) patients treated with erlotinib (E) or gefitinib (G)
29. DIFFERENCE IN SKIN TOXICITY INCIDENCE BETWEEN ERLOTINIB (E) AND GEFITINIB (G) IN THE TREATMENT OF ADVANCED NON-SMALL-CELL LUNG CANCER (NSCLC)
30. The potential predictive role of peripheral circulating T lymphocyte sub-populations during treatment with nivolumab for advanced non-small cell lung cancer
31. Gefitinib (G) treatment outcome after progression on erlotinib (E) in patients with advanced non-small-cell lung cancer (NSCLC)
32. The relevance of CEA and CYFRA21-1 as predictive factors in nivolumab treated advanced non-small cell lung cancer (NSCLC) patients
33. Biological mechanism of acquired resistance to the EGFR irreversible inhibitor BIBW-2992 in EGFR-mutant non small cell lung cancer cell line
34. Temperature structuring of microbial communities on a global scale.
35. Caenorhabditis elegans foraging patterns follow a simple rule of thumb.
36. Warmer temperatures favor slower-growing bacteria in natural marine communities.
37. Resource-diversity relationships in bacterial communities reflect the network structure of microbial metabolism.
38. Author Correction: Resource-diversity relationships in bacterial communities reflect the network structure of microbial metabolism.
39. Inversion of pheromone preference optimizes foraging in C. elegans .
40. COVID-19 mortality risk assessment: An international multi-center study.
41. Prognostic Relevance of Circulating Tumor Cells and Circulating Cell-Free DNA Association in Metastatic Non-Small Cell Lung Cancer Treated with Nivolumab.
42. Bottom-Up Approaches to Synthetic Cooperation in Microbial Communities.
43. Temporal clustering of extreme climate events drives a regime shift in rocky intertidal biofilms.
44. Hybrid datasets: integrating observations with experiments in the era of macroecology and big data.
45. Legacy effects and memory loss: how contingencies moderate the response of rocky intertidal biofilms to present and past extreme events.
46. Vinflunine for the treatment of non-small cell lung cancer.
47. [Mental disorders and working capacity evaluation in psychiatric boards].
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.